NFKB1 and nasopharyngeal carcinoma: The upstream component of NF‐κB or the targeted gene of NF-κB has also been reported to contribute to aberrant NF-κB pathway activation [37, 43, 44], MiR-125b has been shown to regulate NF-κB pathway activity by targeting A20 in NPC cells [45].